Delivery Order N6264520D5002-N6264520F0310
Award Date 10/1/20
Potential Completion Date 9/30/21
Potential Value $739K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Portsmouth, VA 23708, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The Defense Health Agency (DOD) awarded a $250,000 firm fixed price delivery order contract to Cardinal Health 414, LLC Nphs Division for the provision of radiopharmaceuticals. The prime contractor, Cardinal Health 414, LLC Nphs Division, is a subsidiary of Cardinal Health, Inc. The contract has a period of performance starting on October 1, 2022 through September 30, 2023 and will be performed in Dublin, Ohio.</p>
- This is a firm fixed-price delivery order awarded by the Defense Health Agency (DHA) to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., for the supply of radiopharmaceutical products. The $738,865.37 contract covers the period from October 1, 2021, to September 30, 2022, and supports the DHA's nuclear medicine and diagnostic imaging requirements. Cardinal Health 414, LLC is a prominent supplier of specialized medical isotopes and radiopharmaceutical therapies to federal...
- This is a firm fixed-price delivery order worth $1,116,048.58 awarded by the Defense Health Agency (DHA) to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the supply of radiopharmaceutical supplies, which are critical for nuclear medicine, oncology, and diagnostic imaging services across federal healthcare facilities. Cardinal Health 414, LLC is an established provider of specialized medical isotopes and radiopharmaceutical therapies to federal agencies,...
- This is a federal contract award to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., for the delivery of radiopharmaceutical supplies. The contract, valued at $358,406.52, was awarded by the Defense Health Agency (DHA) and has an ultimate completion date of October 1, 2024. It is a Firm Fixed Price Delivery Order contract, with no set-aside designation. Cardinal Health 414 is a major supplier of radiopharmaceuticals, radioactive isotopes, and specialized pharmaceutical products...
- This federal contract award is for the delivery of radiopharmaceuticals to the Defense Health Agency (DHA). The $145,418.67 fixed-price delivery order was transferred from a previous agency to DHA and has a completion date of September 30, 2021. The prime contractor is Cardinal Health 414, LLC, a subsidiary of the global healthcare company Cardinal Health, Inc. Cardinal Health 414 is a prominent supplier of radiopharmaceuticals and specialized medical products to federal healthcare agencies,...
- The Defense Health Agency awarded a firm fixed price delivery order contract worth up to $250,000.00 to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., for the provision of radiopharmaceuticals. The contract, which has no set-aside designation, will run through September 30, 2022. Cardinal Health 414 has previously held multiple indefinite delivery contracts to supply radiopharmaceuticals, radioactive isotopes, and other nuclear medicine products and services to the Department...
- Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., has been awarded a $97,824.65 firm fixed price call against the Defense Health Agency's Basic Purchasing Agreement (BPA) for radiological pharmaceuticals. Under this contract, Cardinal Health will provide radiological products to support the Defense Health Agency's medical programs through January 31, 2022 at its facility in Bethesda, Maryland. No set-aside designation was applied to this procurement. Cardinal Health will serve...
- Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., was awarded a delivery order contract by the Defense Health Agency for radiopharmaceuticals with a ceiling value of $563,789.91 under a firm fixed-price arrangement. The award, issued on October 7, 2021, with an ultimate completion date of September 30, 2026, carries no set-aside designation and reflects performance at the awardee's Jacksonville, Florida facility. Cardinal Health 414 specializes in the manufacturing, testing, and...
- This federal contract award to Cardinal Health 414, LLC Nphs Division, a subsidiary of Cardinal Health, Inc., is for the provision of various radiopharmaceuticals to the Defense Health Agency (DHA). The contract, with a ceiling value of $1,200,000.00, has an ultimate completion date of September 30, 2024. It is a Blanket Purchase Agreement (BPA) call, with a Firm Fixed Price (FFP) pricing type. The contract supports the DHA's mission to provide comprehensive healthcare services, including...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Cardinal Health, Inc., a global healthcare services and products company, for $1,385.96. The contract is for the provision of pharmaceutical and medical supplies, including radiopharmaceutical products, to support the DLA's Pharmaceutical Prime Vendor program, which supplies medical products to military treatment facilities and deployed troops worldwide. The contract is a firm fixed-price delivery order with no set-aside...
- N6264520D5002Indefinite Delivery Contract
- N6264520D5002-N6264520F0310Delivery Order
Cardinal Health 414, LLC Nphs Division was awarded a $738,865.37 firm fixed price delivery order contract by the Defense Health Agency of the Department of Defense to provide radiopharmaceutical supplies. The contract has a one-year period of performance starting October 1, 2020 through September 30, 2021 and will be carried out in Portsmouth, Virginia. As a major supplier of medical products and services to government customers, Cardinal Health will leverage its expertise and infrastructure to ensure the timely delivery of these critical radioactive materials used in nuclear medicine diagnostic procedures for DHA-supported military treatment facilities.
Generated 12/25/23, 3:12 AM
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
NMCP RADIOPHARMACEUTICALS | N6264519R0087 | Department of the Navy Bureau of Medicine and Surgery | Solicitation 1/1 | 9/30/19, 12:46 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Other Administrative Action | $446.9k | 2/2/21 | |
| P00001 | Other Administrative Action | $0 | 12/5/20 | |
| Not listed | Not listed | $0 | 9/30/20 |